GlobalData on MSN4d
Junshi partners LEO Pharma for toripalimab distribution in Europe
Shanghai Junshi Biosciences and its subsidiary TopAlliance Biosciences are set to enter a collaboration with LEO Pharma to ...
The Pharma Letter5d
Junshi partners with LEO Pharma for toripalimab in Europe
China’s Junshi Biosciences yesterday revealed that its wholly-owned subsidiary TopAlliance Bioscience has entered into a ...
FiercePharma4d
Leo bags EU rights to Junshi's Loqtorzi, putting marketing muscle behind PD-1 launch
Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...
manilatimes6d
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
Toripalimab, independently developed by Junshi Biosciences, is a monoclonal antibody targeting PD-1 for the treatment of ...
PMLiVE3d
LEO pharma gains EU rights to Junshi Biosciences’ PD-1 inhibitor toripalimab
LEO Pharma will be gaining the rights to commercialise Junshi Biosciences’ toripalimab in Europe under a new distribution and ...
emjreviews.com5d
LEO Pharma to market Junshi Biosciences’s toripalimab
Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the ...
Pharmabiz4d
Junshi Biosciences enters distribution and marketing partnership with LEO Pharma for toripalimab in Europe
Junshi Biosciences enters distribution and marketing partnership with LEO Pharma for toripalimab in Europe: Shanghai, China Wednesday, January 22, 2025, 14:00 Hrs [IST] Shanghai J ...
Business Insider6d
Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
Under the agreement, LEO Pharma will be responsible for toripalimab’s distribution, promotion, sales, etc., in up to 32 countries, including all member states of the European Union (EU ...